RefleXion valuation, funding and investors
RefleXion works in biotargeted radiotherapy technology development, based in Hayward, United States. Founded in 2009, it has about 123 employees.
VALUATION · TODAY
$384M −45% after Growth
Range $219M – $888M · Grade CTODAY
+12 MO
$500M
$1.00B
$1.50B
$2.00B
2010
2012
2014
2016
2018
2020
2022
2024
2026
Series A $11.6M
Series B $37.0M
Series C $100M
Series D $80.0M
Growth $105M
ValuationBefore first round12-month outlook: where it points, how wide it fansHover the past: the outlook shows what was predicted then
HEADCOUNT · TODAY123 employees
−37%6m growth
−47%1y growth
−51%2y growth
100
200
300
Data from Jan 2021
Predicted in 1 yr $211M −45% vs today
Predicted next raise $98.8M if a round comes
Winding-down probability 97%
- Last round
- Growth · $105M · Nov 2023
- Valuation at last round
- $1.18B · implied
- Headcount
- 123 · shrinking
- Grade
- C
- Founded
- 2009
RefleXion valuation today
VCMC values RefleXion at $384M today, with a range of $219M to $888M and a grade of C. The valuation starts from its last funding round, a growth round in Nov 2023.
Valuation by date (220 rows)
Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.
| Date | Valuation | Range | Predicted in 1 yr | Phase | Headcount | Trend | Grade | Winding-down probability |
|---|---|---|---|---|---|---|---|---|
| 1 Jan 2009 | $4.67M | $1.70M – $12.8M | $4.67M (0%) | before first round | – | unknown | D | 0% |
| 1 Feb 2009 | $4.67M | $1.70M – $12.8M | $4.67M (0%) | before first round | – | unknown | D | 0% |
| 1 Mar 2009 | $4.67M | $1.70M – $12.8M | $4.67M (0%) | before first round | – | unknown | D | 0% |
| 1 Apr 2009 | $4.67M | $1.70M – $12.8M | $4.67M (0%) | before first round | – | unknown | D | 0% |
| 1 May 2009 | $4.67M | $1.70M – $12.8M | $4.67M (0%) | before first round | – | unknown | D | 0% |
| 1 Jun 2009 | $4.67M | $1.70M – $12.8M | $4.67M (0%) | before first round | – | unknown | D | 0% |
| 1 Jul 2009 | $4.67M | $1.70M – $12.8M | $4.67M (0%) | before first round | – | unknown | D | 0% |
| 1 Aug 2009 | $4.67M | $1.70M – $12.8M | $4.67M (0%) | before first round | – | unknown | D | 0% |
| 1 Sep 2009 | $4.67M | $1.70M – $12.8M | $4.67M (0%) | before first round | – | unknown | D | 0% |
| 1 Oct 2009 | $4.67M | $1.70M – $12.8M | $4.67M (0%) | before first round | – | unknown | D | 0% |
| 1 Nov 2009 | $4.67M | $1.70M – $12.8M | $4.67M (0%) | before first round | – | unknown | D | 0% |
| 1 Dec 2009 | $4.67M | $1.70M – $12.8M | $4.67M (0%) | before first round | – | unknown | D | 0% |
| 1 Jan 2010 | $4.67M | $1.70M – $12.8M | $4.67M (0%) | before first round | – | unknown | D | 0% |
| 1 Feb 2010 | $4.67M | $1.70M – $12.8M | $4.67M (0%) | before first round | – | unknown | D | 0% |
| 1 Mar 2010 | $4.67M | $1.70M – $12.8M | $4.67M (0%) | before first round | – | unknown | D | 0% |
| 1 Apr 2010 | $4.67M | $1.70M – $12.8M | $4.67M (0%) | before first round | – | unknown | D | 0% |
| 1 May 2010 | $4.67M | $1.70M – $12.8M | $4.67M (0%) | before first round | – | unknown | D | 0% |
| 1 Jun 2010 | $4.67M | $1.70M – $12.8M | $4.67M (0%) | before first round | – | unknown | D | 0% |
| 1 Jul 2010 | $4.67M | $1.70M – $12.8M | $4.67M (0%) | before first round | – | unknown | D | 0% |
| 1 Aug 2010 | $4.67M | $1.70M – $12.8M | $4.67M (0%) | before first round | – | unknown | D | 0% |
| 1 Sep 2010 | $4.67M | $1.70M – $12.8M | $4.67M (0%) | before first round | – | unknown | D | 0% |
| 1 Oct 2010 | $4.67M | $1.70M – $12.8M | $4.67M (0%) | before first round | – | unknown | D | 0% |
| 1 Nov 2010 | $4.67M | $1.70M – $12.8M | $4.67M (0%) | before first round | – | unknown | D | 0% |
| 1 Dec 2010 | $4.67M | $1.70M – $12.8M | $4.67M (0%) | before first round | – | unknown | D | 0% |
| 1 Jan 2011 | $4.67M | $1.70M – $12.8M | $4.67M (0%) | before first round | – | unknown | D | 0% |
| 1 Feb 2011 | $4.67M | $1.70M – $12.8M | $4.67M (0%) | before first round | – | unknown | D | 0% |
| 1 Mar 2011 | $4.67M | $1.70M – $12.8M | $4.67M (0%) | before first round | – | unknown | D | 0% |
| 1 Apr 2011 | $4.67M | $1.70M – $12.8M | $4.67M (0%) | before first round | – | unknown | D | 0% |
| 1 May 2011 | $4.67M | $1.70M – $12.8M | $4.67M (0%) | before first round | – | unknown | D | 0% |
| 1 Jun 2011 | $4.67M | $1.70M – $12.8M | $4.67M (0%) | before first round | – | unknown | D | 0% |
| 1 Jul 2011 | $4.67M | $1.70M – $12.8M | $4.67M (0%) | before first round | – | unknown | D | 0% |
| 1 Aug 2011 | $4.67M | $1.70M – $12.8M | $4.69M (0%) | before first round | – | unknown | D | 0% |
| 1 Sep 2011 | $4.67M | $1.70M – $12.8M | $4.71M (+1%) | before first round | – | unknown | D | 0% |
| 1 Oct 2011 | $4.67M | $1.70M – $12.8M | $4.73M (+1%) | before first round | – | unknown | D | 0% |
| 1 Nov 2011 | $4.67M | $1.70M – $12.8M | $4.75M (+2%) | before first round | – | unknown | D | 0% |
| 1 Dec 2011 | $4.67M | $1.70M – $12.8M | $4.77M (+2%) | before first round | – | unknown | D | 0% |
| 1 Jan 2012 | $4.67M | $1.70M – $12.8M | $4.78M (+2%) | before first round | – | unknown | D | 0% |
| 1 Feb 2012 | $4.67M | $1.70M – $12.8M | $4.80M (+3%) | before first round | – | unknown | D | 0% |
| 1 Mar 2012 | $4.67M | $1.70M – $12.8M | $4.82M (+3%) | before first round | – | unknown | D | 0% |
| 1 Apr 2012 | $4.67M | $1.70M – $12.8M | $4.84M (+4%) | before first round | – | unknown | D | 0% |
| 1 May 2012 | $4.67M | $1.70M – $12.8M | $4.86M (+4%) | before first round | – | unknown | D | 0% |
| 1 Jun 2012 | $4.67M | $1.70M – $12.8M | $4.88M (+4%) | before first round | – | unknown | D | 0% |
| 1 Jul 2012 | $4.67M | $1.70M – $12.8M | $4.90M (+5%) | before first round | – | unknown | D | 0% |
| 1 Aug 2012 | $4.69M | $1.71M – $12.9M | $4.92M (+5%) | before first round | – | unknown | D | 0% |
| 1 Sep 2012 | $4.71M | $1.71M – $12.9M | $4.94M (+5%) | before first round | – | unknown | D | 0% |
| 1 Oct 2012 | $4.73M | $1.72M – $13.0M | $4.96M (+5%) | before first round | – | unknown | D | 0% |
| 1 Nov 2012 | $4.75M | $1.73M – $13.0M | $4.98M (+5%) | before first round | – | unknown | D | 0% |
| 1 Dec 2012 | $4.77M | $1.74M – $13.1M | $4.99M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jan 2013 | $4.78M | $1.74M – $13.1M | $5.01M (+5%) | before first round | – | unknown | D | 0% |
| 1 Feb 2013 | $4.80M | $1.75M – $13.2M | $5.03M (+5%) | before first round | – | unknown | D | 0% |
| 1 Mar 2013 | $4.82M | $1.75M – $13.2M | $5.05M (+5%) | before first round | – | unknown | D | 0% |
| 1 Apr 2013 | $4.84M | $1.76M – $13.3M | $5.07M (+5%) | before first round | – | unknown | D | 0% |
| 1 May 2013 | $4.86M | $1.77M – $13.3M | $5.09M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jun 2013 | $4.88M | $1.78M – $13.4M | $5.11M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jul 2013 | $4.90M | $1.78M – $13.5M | $5.13M (+5%) | before first round | – | unknown | D | 0% |
| 1 Aug 2013 | $4.92M | $1.79M – $13.5M | $5.15M (+5%) | before first round | – | unknown | D | 0% |
| 1 Sep 2013 | $4.94M | $1.80M – $13.6M | $5.17M (+5%) | before first round | – | unknown | D | 0% |
| 1 Oct 2013 | $4.95M | $1.80M – $13.6M | $5.19M (+5%) | before first round | – | unknown | D | 0% |
| 1 Nov 2013 | $4.97M | $1.81M – $13.7M | $5.21M (+5%) | before first round | – | unknown | D | 0% |
| 1 Dec 2013 | $4.99M | $1.82M – $13.7M | $5.23M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jan 2014 | $5.01M | $1.83M – $13.8M | $5.25M (+5%) | before first round | – | unknown | D | 0% |
| 1 Feb 2014 | $5.03M | $1.83M – $13.8M | $5.28M (+5%) | before first round | – | unknown | D | 0% |
| 1 Mar 2014 | $5.05M | $1.84M – $13.9M | $5.29M (+5%) | before first round | – | unknown | D | 0% |
| 1 Apr 2014 | $5.07M | $1.85M – $13.9M | $5.32M (+5%) | before first round | – | unknown | D | 0% |
| 4 Apr 2014 | $64.5M | $42.3M – $177M | $116M (+80%) | after a round | – | unknown | C | 0% |
| 1 May 2014 | $67.4M | $42.3M – $177M | $116M (+72%) | after a round | – | unknown | C | 0% |
| 1 Jun 2014 | $70.9M | $42.3M – $177M | $116M (+64%) | after a round | – | unknown | C | 0% |
| 1 Jul 2014 | $74.4M | $42.3M – $177M | $116M (+56%) | after a round | – | unknown | C | 0% |
| 1 Aug 2014 | $78.2M | $42.3M – $177M | $116M (+48%) | after a round | – | unknown | C | 0% |
| 1 Sep 2014 | $82.2M | $42.3M – $177M | $116M (+41%) | after a round | – | unknown | C | 0% |
| 1 Oct 2014 | $86.2M | $42.3M – $177M | $116M (+35%) | after a round | – | unknown | C | 0% |
| 1 Nov 2014 | $90.6M | $42.3M – $177M | $116M (+28%) | after a round | – | unknown | C | 0% |
| 1 Dec 2014 | $95.1M | $42.3M – $177M | $116M (+22%) | after a round | – | unknown | C | 0% |
| 1 Jan 2015 | $100M | $42.3M – $177M | $116M (+16%) | after a round | – | unknown | C | 0% |
| 1 Feb 2015 | $105M | $42.3M – $177M | $116M (+10%) | after a round | – | unknown | C | 0% |
| 1 Mar 2015 | $110M | $42.3M – $177M | $116M (+5%) | after a round | – | unknown | C | 0% |
| 1 Apr 2015 | $116M | $42.3M – $177M | $116M (0%) | after a round | – | unknown | C | 0% |
| 1 May 2015 | $116M | $40.5M – $177M | $116M (0%) | after a round | – | unknown | C | 0% |
| 1 Jun 2015 | $116M | $38.4M – $177M | $116M (0%) | after a round | – | unknown | C | 0% |
| 1 Jul 2015 | $116M | $36.6M – $177M | $116M (0%) | after a round | – | unknown | C | 0% |
| 1 Aug 2015 | $116M | $34.8M – $177M | $116M (0%) | after a round | – | unknown | C | 0% |
| 1 Sep 2015 | $116M | $33.1M – $177M | $116M (0%) | after a round | – | unknown | C | 0% |
| 1 Oct 2015 | $116M | $31.5M – $177M | $116M (0%) | after a round | – | unknown | C | 0% |
| 1 Nov 2015 | $116M | $29.9M – $177M | $116M (0%) | after a round | – | unknown | C | 0% |
| 1 Dec 2015 | $116M | $28.5M – $177M | $116M (0%) | after a round | – | unknown | C | 0% |
| 1 Jan 2016 | $116M | $27.1M – $177M | $116M (0%) | after a round | – | unknown | C | 0% |
| 1 Feb 2016 | $116M | $25.7M – $177M | $116M (0%) | after a round | – | unknown | C | 0% |
| 1 Mar 2016 | $116M | $24.5M – $177M | $116M (0%) | after a round | – | unknown | C | 0% |
| 1 Apr 2016 | $116M | $23.3M – $177M | $116M (0%) | after a round | – | unknown | D | 0% |
| 1 May 2016 | $116M | $22.2M – $177M | $116M (0%) | after a round | – | unknown | D | 0% |
| 1 Jun 2016 | $116M | $21.1M – $177M | $116M (0%) | after a round | – | unknown | D | 0% |
| 1 Jul 2016 | $116M | $20.1M – $177M | $116M (0%) | after a round | – | unknown | D | 0% |
| 20 Jul 2016 | $240M | $169M – $511M | $360M (+50%) | after a round | – | unknown | B | 0% |
| 1 Aug 2016 | $244M | $169M – $511M | $360M (+48%) | after a round | – | unknown | B | 0% |
| 1 Sep 2016 | $252M | $169M – $511M | $360M (+43%) | after a round | – | unknown | B | 0% |
| 1 Oct 2016 | $261M | $169M – $511M | $360M (+38%) | after a round | – | unknown | B | 0% |
| 1 Nov 2016 | $270M | $169M – $511M | $360M (+33%) | after a round | – | unknown | B | 0% |
| 1 Dec 2016 | $279M | $169M – $511M | $360M (+29%) | after a round | – | unknown | B | 0% |
| 1 Jan 2017 | $289M | $169M – $511M | $360M (+25%) | after a round | – | unknown | B | 0% |
| 1 Feb 2017 | $299M | $169M – $511M | $360M (+21%) | after a round | – | unknown | B | 0% |
| 1 Mar 2017 | $308M | $169M – $511M | $360M (+17%) | after a round | – | unknown | B | 0% |
| 1 Apr 2017 | $319M | $169M – $511M | $360M (+13%) | after a round | – | unknown | B | 0% |
| 1 May 2017 | $330M | $169M – $511M | $360M (+9%) | after a round | – | unknown | B | 0% |
| 1 Jun 2017 | $341M | $169M – $511M | $360M (+6%) | after a round | – | unknown | B | 0% |
| 1 Jul 2017 | $353M | $169M – $511M | $360M (+2%) | after a round | – | unknown | B | 0% |
| 1 Aug 2017 | $360M | $166M – $511M | $360M (0%) | after a round | – | unknown | B | 0% |
| 1 Sep 2017 | $360M | $159M – $511M | $360M (0%) | after a round | – | unknown | B | 0% |
| 1 Oct 2017 | $360M | $152M – $511M | $360M (0%) | after a round | – | unknown | C | 0% |
| 1 Nov 2017 | $360M | $146M – $511M | $360M (0%) | after a round | – | unknown | C | 0% |
| 1 Dec 2017 | $360M | $140M – $511M | $360M (0%) | after a round | – | unknown | C | 0% |
| 1 Jan 2018 | $360M | $134M – $511M | $360M (0%) | after a round | – | unknown | C | 0% |
| 1 Feb 2018 | $360M | $128M – $511M | $360M (0%) | after a round | – | unknown | C | 0% |
| 1 Mar 2018 | $360M | $123M – $511M | $360M (0%) | after a round | – | unknown | C | 0% |
| 1 Apr 2018 | $360M | $118M – $511M | $360M (0%) | after a round | – | unknown | C | 0% |
| 5 Apr 2018 | $745M | $525M – $1.4B | $968M (+30%) | after a round | – | unknown | B | 0% |
| 1 May 2018 | $759M | $525M – $1.4B | $968M (+28%) | after a round | – | unknown | B | 0% |
| 1 Jun 2018 | $777M | $525M – $1.4B | $968M (+25%) | after a round | – | unknown | B | 0% |
| 1 Jul 2018 | $793M | $525M – $1.4B | $968M (+22%) | after a round | – | unknown | B | 0% |
| 1 Aug 2018 | $811M | $525M – $1.4B | $968M (+19%) | after a round | – | unknown | B | 0% |
| 1 Sep 2018 | $830M | $525M – $1.4B | $968M (+17%) | after a round | – | unknown | B | 0% |
| 1 Oct 2018 | $848M | $525M – $1.4B | $968M (+14%) | after a round | – | unknown | B | 0% |
| 1 Nov 2018 | $867M | $525M – $1.4B | $968M (+12%) | after a round | – | unknown | B | 0% |
| 1 Dec 2018 | $886M | $525M – $1.4B | $968M (+9%) | after a round | – | unknown | B | 0% |
| 1 Jan 2019 | $906M | $525M – $1.4B | $968M (+7%) | after a round | – | unknown | B | 0% |
| 1 Feb 2019 | $926M | $525M – $1.4B | $968M (+5%) | after a round | – | unknown | B | 0% |
| 1 Mar 2019 | $945M | $525M – $1.4B | $968M (+2%) | after a round | – | unknown | B | 0% |
| 1 Apr 2019 | $966M | $525M – $1.4B | $968M (0%) | after a round | – | unknown | B | 0% |
| 1 May 2019 | $968M | $504M – $1.4B | $968M (0%) | after a round | – | unknown | B | 0% |
| 1 Jun 2019 | $968M | $481M – $1.4B | $968M (0%) | after a round | – | unknown | B | 0% |
| 1 Jul 2019 | $968M | $460M – $1.4B | $968M (0%) | after a round | – | unknown | B | 0% |
| 1 Aug 2019 | $968M | $439M – $1.4B | $968M (0%) | after a round | – | unknown | B | 0% |
| 1 Sep 2019 | $968M | $420M – $1.4B | $968M (0%) | after a round | – | unknown | B | 0% |
| 1 Oct 2019 | $968M | $401M – $1.4B | $968M (0%) | after a round | – | unknown | C | 0% |
| 1 Nov 2019 | $968M | $383M – $1.4B | $968M (0%) | after a round | – | unknown | C | 0% |
| 1 Dec 2019 | $968M | $366M – $1.4B | $968M (0%) | after a round | – | unknown | C | 0% |
| 1 Jan 2020 | $968M | $349M – $1.4B | $968M (0%) | after a round | – | unknown | C | 0% |
| 1 Feb 2020 | $968M | $334M – $1.4B | $968M (0%) | after a round | – | unknown | C | 0% |
| 1 Mar 2020 | $968M | $319M – $1.4B | $968M (0%) | after a round | – | unknown | C | 0% |
| 1 Apr 2020 | $968M | $305M – $1.4B | $968M (0%) | after a round | – | unknown | C | 0% |
| 1 May 2020 | $968M | $275M – $1.4B | $968M (0%) | after a round | – | unknown | C | 0% |
| 1 Jun 2020 | $968M | $262M – $1.4B | $968M (0%) | after a round | – | unknown | C | 0% |
| 1 Jul 2020 | $968M | $249M – $1.4B | $968M (0%) | after a round | – | unknown | C | 0% |
| 1 Aug 2020 | $968M | $237M – $1.4B | $968M (0%) | after a round | – | unknown | C | 0% |
| 1 Sep 2020 | $968M | $225M – $1.4B | $968M (0%) | after a round | – | unknown | C | 0% |
| 1 Oct 2020 | $968M | $214M – $1.4B | $968M (0%) | after a round | – | unknown | C | 0% |
| 1 Nov 2020 | $968M | $204M – $1.4B | $968M (0%) | after a round | – | unknown | C | 0% |
| 1 Dec 2020 | $968M | $194M – $1.4B | $968M (0%) | after a round | – | unknown | C | 0% |
| 1 Jan 2021 | $968M | $184M – $1.4B | $968M (0%) | after a round | 200 | unknown | D | 0% |
| 1 Feb 2021 | $968M | $175M – $1.4B | $968M (0%) | after a round | 200 | unknown | D | 0% |
| 1 Mar 2021 | $968M | $167M – $1.4B | $968M (0%) | after a round | 200 | unknown | D | 0% |
| 1 Apr 2021 | $968M | $159M – $1.4B | $877M (-9%) | after a round | 200 | flat | D | 0% |
| 1 May 2021 | $961M | $151M – $1.4B | $870M (-10%) | after a round | 200 | flat | D | 0% |
| 1 Jun 2021 | $953M | $144M – $1.4B | $862M (-10%) | after a round | 200 | flat | D | 0% |
| 1 Jul 2021 | $945M | $137M – $1.3B | $855M (-10%) | after a round | 200 | flat | D | 0% |
| 1 Aug 2021 | $937M | $130M – $1.3B | $848M (-10%) | after a round | 200 | flat | D | 0% |
| 1 Sep 2021 | $929M | $124M – $1.3B | $841M (-10%) | after a round | 200 | flat | D | 0% |
| 1 Oct 2021 | $922M | $118M – $1.3B | $834M (-10%) | after a round | 200 | flat | D | 0% |
| 1 Nov 2021 | $914M | $112M – $1.3B | $827M (-10%) | after a round | 200 | flat | D | 0% |
| 1 Dec 2021 | $906M | $106M – $1.3B | $820M (-10%) | after a round | 200 | flat | D | 0% |
| 1 Jan 2022 | $899M | $101M – $1.3B | $813M (-10%) | after a round | 200 | flat | D | 0% |
| 1 Feb 2022 | $891M | $96.1M – $1.3B | $806M (-10%) | after a round | 200 | flat | D | 0% |
| 1 Mar 2022 | $951M | $188M – $1.3B | $932M (-2%) | after a round | 250 | up | C | 0% |
| 11 Mar 2022 | $1.0B | $657M – $2.0B | $1.3B (+30%) | after a round | 250 | up | B | 0% |
| 1 Apr 2022 | $1.0B | $657M – $2.0B | $1.3B (+28%) | after a round | 250 | up | B | 0% |
| 1 May 2022 | $1.0B | $657M – $2.0B | $1.3B (+25%) | after a round | 250 | up | B | 0% |
| 1 Jun 2022 | $1.1B | $657M – $2.0B | $1.3B (+22%) | after a round | 250 | up | B | 0% |
| 1 Jul 2022 | $1.1B | $657M – $2.0B | $1.3B (+20%) | after a round | 250 | up | B | 0% |
| 1 Aug 2022 | $1.1B | $657M – $2.0B | $1.3B (+17%) | after a round | 250 | up | B | 0% |
| 1 Sep 2022 | $1.1B | $657M – $2.0B | $1.3B (+15%) | after a round | 250 | up | B | 0% |
| 1 Oct 2022 | $1.2B | $657M – $2.0B | $1.3B (+12%) | after a round | 250 | up | B | 0% |
| 1 Nov 2022 | $1.2B | $657M – $2.0B | $1.3B (+10%) | after a round | 250 | unknown | B | 0% |
| 1 Dec 2022 | $1.2B | $657M – $2.0B | $1.3B (+7%) | after a round | 250 | unknown | B | 0% |
| 1 Jan 2023 | $1.2B | $657M – $2.0B | $1.3B (+5%) | after a round | 250 | unknown | B | 0% |
| 1 Feb 2023 | $1.3B | $657M – $2.0B | $1.3B (+3%) | after a round | 250 | unknown | B | 0% |
| 1 Mar 2023 | $1.3B | $657M – $2.0B | $1.3B (+1%) | after a round | 250 | unknown | B | 0% |
| 1 Apr 2023 | $1.3B | $642M – $2.0B | $1.3B (0%) | after a round | 260 | flat | B | 0% |
| 1 May 2023 | $1.3B | $613M – $2.0B | $1.3B (0%) | after a round | 260 | flat | B | 0% |
| 1 Jun 2023 | $1.3B | $586M – $2.0B | $1.3B (0%) | after a round | 260 | flat | C | 0% |
| 1 Jul 2023 | $1.3B | $560M – $2.0B | $1.3B (0%) | after a round | 260 | flat | C | 0% |
| 1 Aug 2023 | $1.3B | $534M – $2.0B | $1.3B (0%) | after a round | 260 | flat | C | 0% |
| 1 Sep 2023 | $1.3B | $510M – $2.0B | $1.3B (0%) | after a round | 260 | flat | C | 0% |
| 1 Oct 2023 | $1.3B | $488M – $2.0B | $1.3B (0%) | after a round | 260 | flat | C | 0% |
| 1 Nov 2023 | $1.3B | $466M – $2.0B | $1.3B (0%) | after a round | 260 | flat | C | 0% |
| 16 Nov 2023 | $1.2B | $829M – $1.8B | $1.3B (+10%) | after a round | 260 | flat | B | 0% |
| 1 Dec 2023 | $1.2B | $829M – $1.8B | $1.3B (+10%) | after a round | 260 | flat | B | 0% |
| 1 Jan 2024 | $1.2B | $829M – $1.8B | $1.3B (+9%) | after a round | 260 | flat | B | 0% |
| 1 Feb 2024 | $1.2B | $822M – $1.8B | $1.2B (+4%) | after a round | 250 | flat | B | 18% |
| 1 Mar 2024 | $1.2B | $822M – $1.8B | $1.2B (+3%) | after a round | 250 | flat | B | 22% |
| 1 Apr 2024 | $1.2B | $822M – $1.8B | $1.2B (+1%) | after a round | 250 | flat | B | 22% |
| 1 May 2024 | $1.2B | $822M – $1.8B | $1.2B (0%) | after a round | 250 | flat | B | 22% |
| 1 Jun 2024 | $1.2B | $822M – $1.8B | $1.2B (-1%) | after a round | 250 | flat | B | 22% |
| 1 Jul 2024 | $1.2B | $822M – $1.8B | $1.2B (-3%) | after a round | 250 | flat | B | 25% |
| 1 Aug 2024 | $1.2B | $822M – $1.8B | $1.2B (-4%) | after a round | 250 | flat | B | 24% |
| 1 Sep 2024 | $1.2B | $822M – $1.8B | $1.2B (-5%) | after a round | 250 | flat | B | 24% |
| 1 Oct 2024 | $1.2B | $822M – $1.8B | $1.2B (-6%) | after a round | 250 | flat | B | 24% |
| 1 Nov 2024 | $1.3B | $829M – $1.8B | $1.2B (-7%) | after a round | 260 | flat | B | 22% |
| 1 Dec 2024 | $1.3B | $806M – $1.8B | $1.2B (-8%) | after a round | 260 | flat | B | 20% |
| 1 Jan 2025 | $1.3B | $766M – $1.8B | $1.2B (-7%) | after a round | 260 | flat | B | 18% |
| 1 Feb 2025 | $1.3B | $728M – $1.8B | $1.2B (-7%) | after a round | 260 | flat | B | 17% |
| 1 Mar 2025 | $1.3B | $695M – $1.8B | $1.2B (-6%) | after a round | 260 | flat | B | 16% |
| 1 Apr 2025 | $1.3B | $661M – $1.8B | $1.2B (-6%) | after a round | 260 | flat | B | 14% |
| 1 May 2025 | $1.3B | $629M – $1.8B | $1.2B (-5%) | after a round | 260 | flat | B | 13% |
| 1 Jun 2025 | $1.2B | $598M – $1.8B | $1.2B (-5%) | after a round | 260 | flat | B | 12% |
| 1 Jul 2025 | $1.2B | $569M – $1.8B | $1.2B (-5%) | after a round | 260 | flat | B | 11% |
| 1 Aug 2025 | $1.1B | $527M – $1.7B | $954M (-14%) | after a round | 230 | flat | B | 36% |
| 1 Sep 2025 | $1.1B | $500M – $1.7B | $900M (-16%) | after a round | 230 | flat | C | 42% |
| 1 Oct 2025 | $1.0B | $476M – $1.7B | $865M (-17%) | after a round | 230 | flat | C | 45% |
| 1 Nov 2025 | $793M | $437M – $1.6B | $523M (-34%) | after a round | 195 | down | C | 97% |
| 1 Dec 2025 | $743M | $416M – $1.6B | $459M (-38%) | after a round | 195 | down | C | 97% |
| 1 Jan 2026 | $719M | $395M – $1.7B | $442M (-38%) | after a round | 195 | down | C | 97% |
| 1 Feb 2026 | $696M | $375M – $1.7B | $426M (-39%) | after a round | 195 | down | C | 97% |
| 1 Mar 2026 | $676M | $358M – $1.7B | $412M (-39%) | after a round | 195 | down | C | 97% |
| 1 Apr 2026 | $654M | $341M – $1.7B | $396M (-39%) | after a round | 195 | down | C | 97% |
| 1 May 2026 | $515M | $310M – $1.1B | $291M (-43%) | after a round | 159 | shrinking | C | 97% |
| 1 Jun 2026 | $494M | $295M – $1.0B | $278M (-44%) | after a round | 159 | shrinking | C | 97% |
| 1 Jul 2026 | $474M | $280M – $1.0B | $267M (-44%) | after a round | 159 | shrinking | C | 97% |
| 1 Aug 2026 | $455M | $267M – $993M | $255M (-44%) | after a round | 159 | shrinking | C | 97% |
| 1 Sep 2026 | $436M | $253M – $973M | $244M (-44%) | after a round | 159 | shrinking | C | 97% |
| 1 Oct 2026 | $396M | $228M – $901M | $220M (-44%) | after a round | 123 | shrinking | C | 97% |
| 24 Oct 2026 | $384M | $219M – $888M | $211M (-45%) | after a round | 123 | shrinking | C | 97% |
Key facts about RefleXion
- Founded
- 2009
- Headquarters
- Hayward, United States
- Employees
- about 123 -37% in a year
- Total raised
- $459M
- Funding rounds
- 6
- Last round
- Growth Equity Nov 2023
RefleXion was founded in 2009 by Akshay Nanduri and Samuel Mazin.
RefleXion funding history
RefleXion has 6 funding rounds on record, from Apr 2014 to Nov 2023, $459M in total. None disclosed a valuation.
Growth Equity 15 Nov 2023
Led by TPG; with Pictet, Square Point Capital, Ally Bridge Group, Pfizer Ventures, Johnson & Johnson Innovation (JJDC Inc.), T. Rowe Price Associates, Inc., Venrock, Catalio Capital Management, Hillenbrand.
Sources: reflexion.com, radiologybusiness.com
$105M
$125M
Series D 10 Mar 2022
Led by Ally Bridge Group; with Ascension, Catalio Capital Management, Sixty Degree Capital, Hillenbrand Capital Partners, TPG, KCK Financial Services, PSP Investments, T. Rowe Price, Venrock, Pfizer Ventures, Johnson & Johnson Innovation, JJDC Inc..
Sources: reflexion.com, sofinnovapartners.com, massdevice.com and 5 more
$80M
Series C 4 Apr 2018
Led by TPG; with T. Rowe Price Associates, Inc., GT Capital, Sofinnova Partners, KCK Financial Services, Venrock, Pfizer Venture Investments, Johnson & Johnson Innovation – JJDC Inc..
Sources: reflexion.com, fiercebiotech.com, globenewswire.com and 2 more
$100M
Series B 19 Jul 2016
With J&J Impact Ventures, KCK Financial Services, Pfizer, Sofinnova Partners, Venrock.
Sources: reflexion.com
$37M
Series A 3 Apr 2014
Led by Sofinnova Partners; with Pfizer Venture Investments, Venrock.
Sources: reflexion.com, globenewswire.com, massdevice.com and 2 more
$12M
RefleXion investors
22 investors have backed RefleXion; Sofinnova Partners, TPG and Ally Bridge Group and 1 more led at least one round.
- TPG lead, 3 rounds
- Oxford Finance lead
- Venrock 5 rounds
- Johnson & Johnson Innovation – JJDC Inc. 3 rounds
- Pfizer Venture Investments 2 rounds
- Pfizer Ventures 2 rounds
- T. Rowe Price Associates, Inc. 2 rounds
- Hillenbrand
- Hillenbrand Capital Partners
- Pfizer
- Pictet
- Square Point Capital
- T. Rowe Price
What RefleXion does
RefleXion works in medical supply manufacturers, with 13 recorded offerings and customers in healthcare and medical equipment.
RefleXion Medical, Inc. is an American biotechnology company engaged in the development and manufacturing of radiotherapy technologies for oncology. The company specializes in biology-guided radiotherapy, which utilizes PET-CT imaging and radiopharmaceuticals to deliver targeted radiation therapy for lung and bone tumors, including metastatic disease. RefleXion also develops theranostic solutions by collaborating with radiopharmaceutical manufacturers to produce tracers for prostate and other high-need cancers. Its technology is supported by a clinical evidence program and a multidisciplinary scientific advisory board.
Description from Veridion's company data.
Products and services
- Biotargeted Radiotherapy Technology Development
- PET-CT Imaging Integration Services
- Motion-Managed Radiotherapy Delivery
- Conformal Dose Delivery Solutions
- Multi-Tumor Treatment Delivery
- Radiopharmaceutical Therapeutic Development
- PSMA Tracer Development
- FAP Tracer Development
- Theranostic Platform Development
- Medical Equipment Manufacturing
- Radiotherapy Machine Manufacturing
- Radiation Therapy Technology Licensing
- Cancer Care Advancement Services
Markets
- Healthcare
- Medical Equipment
Technology
- PET-CT Imaging Integration for Real-Time Tumor Motion Tracking
- Biotargeting Oncology Therapeutics
- Motion-Managed Radiotherapy Delivery
- Fan-Beam KVP Computed Tomography for Real-Time Imaging
- Compact Linear Accelerator for Radiotherapy Delivery
- Binary Multileaf Collimator for Precise Dose Delivery
- Rotating Ring Gantry for Multi-Tumor Treatment
- PET Detector for Tumor Detection
Certifications
- FDA cleared
Business model
- Business-to-Business
- Manufacturing
Industry codes (NAICS)
- 334517 Irradiation Apparatus Manufacturing 100% match
Questions about RefleXion
What is RefleXion worth?
Valuation $384M (range $219M to $888M), as of 24 Oct 2026.
Has RefleXion raised money?
RefleXion has 6 funding rounds on record, from Apr 2014 to Nov 2023, $459M in total. None disclosed a valuation.
Who has invested in RefleXion?
Sofinnova Partners, TPG, Ally Bridge Group, Oxford Finance, Venrock and Johnson & Johnson Innovation – JJDC Inc., and 16 more. Lead investors include Sofinnova Partners, TPG, Ally Bridge Group and Oxford Finance.
How many people work at RefleXion?
About 123, down 37% over the last year. Headcount rose from 200 in Jan 2021 to 260 in Apr 2023, then fell to 123 in Sep 2026.
What does RefleXion do?
RefleXion works in medical supply manufacturers, with 13 recorded offerings and customers in healthcare and medical equipment. Its main offerings are biotargeted radiotherapy technology development, PET-CT imaging integration services and motion-managed radiotherapy delivery.
When was RefleXion founded, and where is it based?
RefleXion was founded in 2009 and is based in Hayward, United States. It has about 123 employees, down 37% over the last year.